Below is information about AEGERA THERAPEUTICS INC HEADQUARTERS from a variety of sources. Please take a look at the materials that our team has selected for you.
https://www.bloomberg.com/profile/company/1046426Z:CN
Company profile page for Aegera Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
https://www.crunchbase.com/organization/aegera-therapeutics-inc
Where is Aegera Therapeutics 's headquarters? Aegera Therapeutics is located in Montréal, Quebec, Canada. Who invested in Aegera Therapeutics? Aegera Therapeutics has 8 investors including Business Development Bank of Canada and Desjardins Venture Capital. How much funding has Aegera Therapeutics raised to date?
https://www.linkedin.com/company/aegera-therapeutics-inc.
Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead …
https://pitchbook.com/profiles/company/52235-11
Contact Information Website www.aegera.com Formerly Known As Exogen Neurosciences Ownership Status Acquired/Merged Financing Status Formerly VC-backed Primary Industry Therapeutic Devices Other Industries Drug Discovery Acquirer Pharmascience Primary Office 810 chemin du Golf Montreal, Quebec H3E 1A8 Canada +1 (514) 000-0000
https://opencorporates.com/companies/ca/7846193
AEGERA THERAPEUTICS INC. Company Number 7846193 Status Dissolved By The Corporation (S. 210) Incorporation Date 25 May 2011 (over 10 years ago) Dissolution Date 23 July 2018 Company Type Non-distributing corporation with 50 or fewer shareholders Jurisdiction Canada Business Number 894407394RC0003 Registered Address 6111 ROYALMOUNT …
https://www.biospace.com/employer/532839/aegera-therapeutics-inc-/
Aegera Therapeutics To Present At Upcoming Investor Conferences. 5/4/2015. Pharmascience Inc. Acquires Aegera Therapeutics; Aegera's Employees to Retain Their Jobs. 5/27/2011. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma. 1/26/2010
https://www.newswire.ca/news-releases/aegera-therapeutics-closes-cdn7-million-financing-538599332.html
MONTREAL , Sept. 23 /CNW Telbec/ - Aegera Therapeutics, a clinical stage biotechnology company focussed on developing targeted therapeutics for oncology and pain, announced today the full drawdown...
https://www.fiercebiotech.com/biotech/pharmascience-inc-acquires-aegera-therapeutics-aegera-s-employees-to-retain-their-jobs
Aegera's 20 plus employees will retain their jobs and will join the Pharmascience team. About Pharmascience Founded in 1983, Pharmascience is a Canadian-owned pharmaceutical company that is based...
https://www.biospace.com/article/releases/aegera-therapeutics-announces-first-close-of-series-c-funding-/
Published: Nov 20, 2006. MONTREAL, Nov. 20 /PRNewswire/ - Aegera Therapeutics Inc. announced today the first closing of their Series C financing, led by The VenGrowth Advanced Life Sciences Fund Inc. and supported by leading Canadian biotechnology funds. This $21 Million Series C Financing, including over $14 Million of equity, along with a ...
https://aeriepharma.com/about/
Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. We have a passion for finding new approaches for protecting or improving vision.
Did you find the information you need about AEGERA THERAPEUTICS INC HEADQUARTERS?
We hope you found all the information about AEGERA THERAPEUTICS INC HEADQUARTERS you were looking for and more.
